In the past week, TECH stock has gone up by 0.38%, with a monthly decline of -14.12% and a quarterly plunge of -29.90%. The volatility ratio for the week is 3.07%, and the volatility levels for the last 30 days are 5.62% for Bio-Techne Corp. The simple moving average for the past 20 days is -1.34% for TECH’s stock, with a -28.06% simple moving average for the past 200 days.
Is It Worth Investing in Bio-Techne Corp (NASDAQ: TECH) Right Now?
The price-to-earnings ratio for Bio-Techne Corp (NASDAQ: TECH) is 51.17x, which is above its average ratio. Moreover, the 36-month beta value for TECH is 1.46. Analysts have varying opinions on the stock, with 8 analysts rating it as a “buy,” 3 as “overweight,” 5 as “hold,” and 0 as “sell.”
The public float for TECH is 156.31M and currently, short sellers hold a 4.13% of that float. On May 01, 2025, TECH’s average trading volume was 2.00M shares.
TECH) stock’s latest price update
Bio-Techne Corp (NASDAQ: TECH)’s stock price has dropped by -0.30 in relation to previous closing price of 50.50. Nevertheless, the company has seen a gain of 0.38% in its stock price over the last five trading days. prnewswire.com reported 2025-04-30 that SCOTTSDALE, Ariz., April 30, 2025 /PRNewswire/ — Cyber Enviro-Tech, Inc. (OTCQB: CETI) announced today that it is conducting critical testing of its advanced water purification technology for the oil and gas industry.
Analysts’ Opinion of TECH
Evercore ISI, on the other hand, stated in their research note that they expect to see TECH reach a price target of $75. The rating they have provided for TECH stocks is “Outperform” according to the report published on March 18th, 2025.
Robert W. Baird gave a rating of “Neutral” to TECH, setting the target price at $68 in the report published on February 19th of the current year.
TECH Trading at -12.31% from the 50-Day Moving Average
After a stumble in the market that brought TECH to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -41.16% of loss for the given period.
Volatility was left at 5.62%, however, over the last 30 days, the volatility rate increased by 3.07%, as shares sank -12.21% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -22.88% lower at present.
During the last 5 trading sessions, TECH rose by +0.38%, which changed the moving average for the period of 200-days by -34.87% in comparison to the 20-day moving average, which settled at $51.03. In addition, Bio-Techne Corp saw -30.10% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at TECH starting from Herr Amy E., who sale 1,860 shares at the price of $65.96 back on Feb 14 ’25. After this action, Herr Amy E. now owns 1,976 shares of Bio-Techne Corp, valued at $122,691 using the latest closing price.
JOSHUA MOLHO, the Domestic Partner of Director of Bio-Techne Corp, proposed sale 1,860 shares at $65.96 during a trade that took place back on Feb 14 ’25, which means that JOSHUA MOLHO is holding shares at $122,691 based on the most recent closing price.
Stock Fundamentals for TECH
Current profitability levels for the company are sitting at:
- 0.2 for the present operating margin
- 0.66 for the gross margin
The net margin for Bio-Techne Corp stands at 0.13. The total capital return value is set at 0.1. Equity return is now at value 7.82, with 5.85 for asset returns.
Based on Bio-Techne Corp (TECH), the company’s capital structure generated 0.16 points at debt to capital in total, while cash flow to debt ratio is standing at 0.77. The debt to equity ratio resting at 0.19. The interest coverage ratio of the stock is 21.99.
Currently, EBITDA for the company is 310.37 million with net debt to EBITDA at 0.64. When we switch over and look at the enterprise to sales, we see a ratio of 6.84. The receivables turnover for the company is 5.49for trailing twelve months and the total asset turnover is 0.45. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.94.
Conclusion
To wrap up, the performance of Bio-Techne Corp (TECH) has been bad in recent times. The stock has received a bullish of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
